R21 CA263415/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2022	1
2023	2
2024	1
2025	0

Page 1

Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma.

Nakhoda S, Vistarop A, Wang YL. Nakhoda S, et al. Br J Haematol. 2023 Jan;200(2):137-149. doi: 10.1111/bjh.18418. Epub 2022 Aug 27. Br J Haematol. 2023. PMID: 36029036 Free PMC article. Review.

Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).

Kim PM, Nejati R, Lu P, Thakkar D, Mackrides N, Dupoux V, Nakhoda S, Baldwin DA, Pei J, Dave SS, Wang YL, Wasik MA. Kim PM, et al. Cold Spring Harb Mol Case Stud. 2024 Jan 10;9(4):a006283. doi: 10.1101/mcs.a006283. Print 2023 Dec. Cold Spring Harb Mol Case Stud. 2024. PMID: 37730436 Free PMC article.

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.

Lu P, Wang S, Franzen CA, Venkataraman G, McClure R, Li L, Wu W, Niu N, Sukhanova M, Pei J, Baldwin DA, Nejati R, Wasik MA, Khan N, Tu Y, Gao J, Chen Y, Ma S, Larson RA, Wang YL. Lu P, et al. Blood Cancer J. 2021 Feb 18;11(2):39. doi: 10.1038/s41408-021-00429-z. Blood Cancer J. 2021. PMID: 33602908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year